Breast cancer proliferative activity: Is it the source of serum free DNA?

被引：2
|
作者：
Hewala, Taha I. [1 ]
El-Moneim, Nadia A. Abd [2 ]
机构：
[1] Alexandria Univ, Med Res Inst, Dept Radiat Sci, 165 Horria Ave,El Hadara, Alexandria 21561, Egypt
[2] Alexandria Univ, Med Res Inst, Dept Canc Management & Res, Alexandria 21561, Egypt
来源：
ALEXANDRIA JOURNAL OF MEDICINE | 2013年 / 49卷 / 04期
关键词：
Breast cancer; Proliferative activity; Diagnosis; Prognosis; DNA; TPS; CEA;
D O I：
10.1016/j.ajme.2013.03.004
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Aim: To study the relationship between serum DNA and breast cancer proliferative activity, then compare the diagnostic and prognostic values of serum DNA, TPS and CEA. Subjects and methods: A total of 100 breast cancer patients before surgery and 50 apparently healthy controls were analyzed for serum DNA, TPS and CEA. Results: Serum DNA levels were nonsignificantly correlated with serum TPS levels. Serum DNA, TPS and CEA levels were significantly higher in patients than controls. Using ROC curve analysis, serum TPS and DNA had the highest AUC compared to serum CEA. Neither serum TPS, DNA nor CEA correlated with breast cancer clinicopathological data. Only serum CEA was significantly correlated with patients' disease-free survival. Conclusion: Neither Breast cancer mass nor proliferative activity is the source of serum free DNA. Serum TPS is superior to DNA and CEA as a diagnostic marker for breast cancer. Only preoperative serum CEA has a prognostic role in predicting relapse of breast cancer patients, but not serum TPS or DNA. (C) 2013 Production and hosting by Elsevier B.V. on behalf of Alexandria University Faculty of Medicine.
引用
收藏
页码：337 / 341
页数：5
相关论文
共 50 条
  • [41] Circulating DNA of HOTAIR in serum is a novel biomarker for breast cancer
    Zhang, Lei
    Song, Xinyun
    Wang, Xiaoxia
    Xie, Yuntao
    Wang, Zengwu
    Xu, Ye
    You, Xin
    Liang, Zicai
    Cao, Huiqing
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 152 (01) : 199 - 208
  • [42] FREE DNA IN SERUM OF CANCER-PATIENTS AND EFFECT OF THERAPY
    LEON, SA
    SHAPIRO, B
    SKLAROFF, DM
    YAROS, MJ
    CANCER RESEARCH, 1977, 37 (03) : 646 - 650
  • [43] SERUM FREE CIRCULATING DNA AS A BIOMARKER FOR PROSTATE CANCER DIAGNOSIS
    Singal, Rakesh
    Gordian, Edna
    Ramachandran, Kavitha
    Katkoori, Devendar
    Reis, Isildinha
    Manoharan, Murugesan
    Soloway, Mark
    JOURNAL OF UROLOGY, 2010, 183 (04): : E671 - E671
  • [44] Clinical relevance of serum-free DNA in colorectal cancer
    Flamini, Emanuela
    Mercatali, Laura
    Rosetti, Paola
    Nanni, Oriana
    Gaudio, Michele
    Calistri, Daniele
    Valenti, Vanessa
    Gardini, Nice
    Lattuneddu, Arturo
    Verdecchia, Giorgio Maria
    Amadori, Dino
    ANNALS OF ONCOLOGY, 2005, 16 : 37 - 37
  • [45] CELL PROLIFERATIVE INDEXES AND DNA CONTENT AS PROGNOSTIC FACTORS IN PRIMARY BREAST-CANCER
    OSBORNE, CK
    HORMONE RESEARCH, 1989, 32 : 238 - 241
  • [46] PROLIFERATIVE MEASUREMENTS IN BREAST-CANCER
    CAMPLEJOHN, RS
    RAIKUNDALIA, B
    VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY, 1995, 427 (03): : 336 - 337
  • [47] FREE - CELL TUMOR DNA AS A BIOMARKER FOR EARLY BREAST CANCER
    Crnobrnja, B.
    Knez, J.
    Sobocan, M.
    Cas-Sikosek, N.
    Vogrin, V.
    Repnik, K.
    Heitzer, E.
    Potocnik, U.
    Takac, I.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A178 - A178
  • [48] Free Circulating Tumor DNA as a Diagnostic Marker for Breast Cancer
    Hashad, D.
    Sorour, A.
    Ghazal, A.
    Talaat, I.
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2012, 26 (06) : 467 - 472
  • [49] Elevated serum arginase activity levels in patients with breast cancer
    Polat, MF
    Taysi, S
    Polat, S
    Böyük, A
    Bakan, E
    SURGERY TODAY, 2003, 33 (09) : 655 - 661
  • [50] MIGRATION STIMULATING ACTIVITY IN SERUM OF BREAST-CANCER PATIENTS
    PICARDO, M
    SCHOR, SL
    GREY, AM
    HOWELL, A
    LAIDLAW, I
    REDFORD, J
    SCHOR, AM
    LANCET, 1991, 337 (8734): : 130 - 133
12345